Dr. Klaus Eyer pursued his BSc and MSc in Pharmaceutical Sciences and received a federal pharmacist diploma from ETH Zürich, Switzerland, between September 2005 and August 2010
He completed his Doctorate in Bioanalytics at ETH Zürich in Switzerland under the supervision of Prof. Dr. P.S. Dittrich in 2014. Following his doctoral studies, he then moved to the ESPCI Paris, first on an SNF advanced postdoctoral grant and a Branco-Weiss Fellowship, working as a postdoctoral fellow and afterward as a junior group leader in the ‘Laboratoire Colloïdes et Matériaux Divisés’ (LCMD) and the ‘Laboratoire de Biochimie’ (LBC). Since August 2019, he has led the Functional Immune Repertoire Analysis group at ETH Zurich in the Institute for Pharmaceutical Sciences.
His group focuses on finding novel ways to measure, understand and advance vaccine-mediated protection towards personalized vaccination strategies and to generate new tools for accelerating decision and treatment finding (i.e., personalized, precision medicine) in rare diseases.
He is a scientific co-founder of SABER Bio SAS, a French start-up company, a member of several professional societies, authored several studies in single-cell and –antibody analysis, and holds several awards and fellowships, such as an ERC-starting Grant #803’363, a Branco-Weiss Fellowship and SNF project grant. He is also a Principal Investigator in the Microbiology and Immunology Ph.D. program and teaches courses on gene technology, vaccination, and ethics in animal research.
